3'-deoxy-3'-[18F]fluorothymidine (FLT)

DRUG2 trials

Sponsors

Genentech, Inc., University of Utah

Conditions

Brain TumorsCancerNon-Small Cell Lung Cancer

Phase 1

A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib

CompletedNCT00453362

Genentech, Inc.Non-Small Cell Lung Cancer

Start: 2006-12-31End: 2010-04-23Updated: 2017-03-31

Multi-Tracer PET Assessment of Primary Brain Tumors

CompletedNCT00813566

University of UtahBrain Tumors, Cancer

Start: 2010-11-12End: 2015-02-03Updated: 2022-04-27